✦ LIBER ✦

Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction

✍ Scribed by Alan K Berger; Sue Duval; Harlan M Krumholz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aspirin, beta-blocker and angiotensin-co

✍ A.K. Berger; S. Duval; H.M. Krumholz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Prognostic Impact of Acute Beta-Blocker

✍ Harm Wienbergen; Uwe Zeymer; Anselm Kai Gitt; Claus Juenger; Rudolf Schiele; Tob 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 92 KB

First dose hypotension after angiotensin

✍ J Spinar; J Vitovec; L Pluhacek; L Spinarova; B Fischerova; J Toman 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Angiotensin Converting Enzyme Inhibitors

✍ Inampudi, Chakradhari; Cotarlan, Vladimir 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 401 KB

Impact of therapy with statins, beta-blo

✍ Gjin Ndrepepa; Siegmund Braun; Albert Schömig; Adnan Kastrati 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 234 KB

Effects of canrenoate plus angiotensin-c

✍ Pietro Di Pasquale; Sergio Cannizzaro; Sebastiano Scalzo; Gaspare Parrinello; Se 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB